Onco-Innovations & Nucro Technics in IND Pact Ahead of Trials
04 Jul 2025 //
ACCESSWIRE
Onco-Innovations CEO Updates Investors on Strategic Milestones
02 Jul 2025 //
ACCESSWIRE
Onco-Innovations Welcomes AstraZeneca`s Interest in PROmAI
27 Jun 2025 //
ACCESSWIRE
Onco-Innovations` CEO Hosts Investors` Call on July 2, 2025
25 Jun 2025 //
ACCESSWIRE
Onco-Innovations Expands PNKP Work with Alberta, Cross Cancer
13 Jun 2025 //
PHARMAWEB
Onco-Innovations` Inka Health Launches AI-Oncology Alliance
05 Jun 2025 //
ACCESSWIRE
Onco-Innovations Extends Marketing Program
26 May 2025 //
ACCESSWIRE
Onco-Innovations Starts Manufacture Preclinical Testing Material
26 May 2025 //
ACCESSWIRE
Onco-Innovations Appoints Steven as Senior Scientific Advisor
22 May 2025 //
ACCESSWIRE
Onco-Innovations Uplists to Cboe Canada
22 May 2025 //
BUSINESSWIRE
Onco-Innovations Lists Common Shares on Cboe Canada
16 May 2025 //
ACCESSWIRE
Onco-Innovations` Inka Health Sign New Work with AstraZeneca Canada
24 Apr 2025 //
ACCESSWIRE
Onco-Innovations partners Dalton Pharma for PNKP Isotope Synthesis
17 Apr 2025 //
ACCESSWIRE
Onco-Innovations Announces Private Placement
16 Apr 2025 //
ACCESSWIRE
Inka Health Publishes Roche-Sponsored Study on Oncology Research
10 Apr 2025 //
ACCESSWIRE
Inka Health Completes Analytics for AstraZeneca Canada
03 Apr 2025 //
ACCESSWIRE
Onco-Innovations` PKNP Tech in Study Shows Low Toxicity
26 Mar 2025 //
ACCESSWIRE
Onco-Innovations Extends Marketing Program
25 Mar 2025 //
ACCESSWIRE
Onco-Innovations Provides Update on Use of Proceeds
24 Mar 2025 //
ACCESSWIRE
Onco-Innovations CEO Talks Cancer Breakthroughs, AI, Expansion
01 Mar 2025 //
ACCESSWIRE
Inka Health’s AI Oncology Study Advances Cancer Research
28 Feb 2025 //
ACCESSWIRE
Onco-Innovations’ Inka AI Oncology Study Advances Research Efforts
27 Feb 2025 //
ACCESSWIRE
Onco-Innovations’ PKNP Tech Shows Low Toxicity, High Safety In Study
24 Feb 2025 //
ACCESSWIRE
Onco-Innovations Shares Inka`s USPTO Filing For AI-Powered SynoGraph
21 Feb 2025 //
ACCESSWIRE
Onco-Innovations Announces U.S. Listing on the OTCQB Market
21 Feb 2025 //
ACCESSWIRE
Onco-Innovations Announces U.S. Listing on the OTCQB Market
20 Feb 2025 //
ACCESSWIRE
Onco-Innovations` PNKP Nanoparticle Slows Colorectal Cancer
14 Feb 2025 //
ACCESSWIRE
Onco-Innovations’ PNKP Inhibitor Boosts Cancer Cell Radiation
10 Feb 2025 //
ACCESSWIRE
Onco-Innovations Acquires Inka Health to Accelerate AI Cancer Drug
03 Feb 2025 //
ACCESSWIRE
Onco-Innovations` Private Placement Fully Subscribed
29 Jan 2025 //
ACCESSWIRE
Onco-Innovations` Tech Shown To Prevent Cancer Cell Regeneration
16 Jan 2025 //
ACCESSWIRE
Onco-Innovations’ Tech Boosts Radiation Therapy via DNA Repair
09 Jan 2025 //
ACCESSWIRE
Onco-Innovations Shares Details on Patented Cancer Drug License
08 Jan 2025 //
ACCESSWIRE